139 related articles for article (PubMed ID: 31810310)
21. Efficacy of combined treatment with alendronate (ALN) and eldecalcitol, a new active vitamin D analog, compared to that of concomitant ALN, vitamin D plus calcium treatment in Japanese patients with primary osteoporosis.
Sakai A; Ito M; Tomomitsu T; Tsurukami H; Ikeda S; Fukuda F; Mizunuma H; Inoue T; Saito H; Nakamura T;
Osteoporos Int; 2015 Mar; 26(3):1193-202. PubMed ID: 25592133
[TBL] [Abstract][Full Text] [Related]
22. [Very old patients with osteoporosis should be treated with alendronate].
Shiraki M
Nihon Ronen Igakkai Zasshi; 2006 Jul; 43(4):455-8. PubMed ID: 16937932
[TBL] [Abstract][Full Text] [Related]
23. Transcutol® P/Cremophor® EL/Ethyl Oleate-Formulated Microemulsion Loaded into Hyaluronic Acid-Based Hydrogel for Improved Transdermal Delivery and Biosafety of Ibuprofen.
Zhang Y; Zhang K; Wang Z; Hu H; Jing Q; Li Y; Guo T; Feng N
AAPS PharmSciTech; 2019 Dec; 21(1):22. PubMed ID: 31823083
[TBL] [Abstract][Full Text] [Related]
24. Alendronate retards the progression of lumbar intervertebral disc degeneration in ovariectomized rats.
Luo Y; Zhang L; Wang WY; Hu QF; Song HP; Su YL; Zhang YZ
Bone; 2013 Aug; 55(2):439-48. PubMed ID: 23500174
[TBL] [Abstract][Full Text] [Related]
25. Clinical efficacy of 1% alendronate gel as a local drug delivery system in the treatment of chronic periodontitis: a randomized, controlled clinical trial.
Sharma A; Pradeep AR
J Periodontol; 2012 Jan; 83(1):11-8. PubMed ID: 21542734
[TBL] [Abstract][Full Text] [Related]
26. Clinical efficacy of 1% alendronate gel in adjunct to mechanotherapy in the treatment of aggressive periodontitis: a randomized controlled clinical trial.
Sharma A; Pradeep AR
J Periodontol; 2012 Jan; 83(1):19-26. PubMed ID: 21609254
[TBL] [Abstract][Full Text] [Related]
27. PLGA-linked alendronate enhances bone repair in diaphysis defect model.
Wang YH; Rajalakshmanan E; Wang CK; Chen CH; Fu YC; Tsai TL; Chang JK; Ho ML
J Tissue Eng Regen Med; 2017 Sep; 11(9):2603-2612. PubMed ID: 27256686
[TBL] [Abstract][Full Text] [Related]
28. The Effect of Alendronate Loaded Biphasic Calcium Phosphate Scaffolds on Bone Regeneration in a Rat Tibial Defect Model.
Park KW; Yun YP; Kim SE; Song HR
Int J Mol Sci; 2015 Nov; 16(11):26738-53. PubMed ID: 26561810
[TBL] [Abstract][Full Text] [Related]
29. Can the alendronate dosage be altered when combined with high-frequency loading in osteoporosis treatment?
Correa CB; Camargos GV; Chatterjee M; Mesquita MF; Del Bel Cury AA; Naert I; Duyck J; Vandamme K
Osteoporos Int; 2017 Apr; 28(4):1287-1293. PubMed ID: 27921147
[TBL] [Abstract][Full Text] [Related]
30. Effects of combined treatment with eldecalcitol and alendronate on bone mass, mechanical properties, and bone histomorphometry in ovariectomized rats: a comparison with alfacalcidol and alendronate.
Sugimoto M; Futaki N; Harada M; Kaku S
Bone; 2013 Jan; 52(1):181-8. PubMed ID: 23041510
[TBL] [Abstract][Full Text] [Related]
31. Dose-response relationships for alendronate treatment in osteoporotic elderly women. Alendronate Elderly Osteoporosis Study Centers.
Bone HG; Downs RW; Tucci JR; Harris ST; Weinstein RS; Licata AA; McClung MR; Kimmel DB; Gertz BJ; Hale E; Polvino WJ
J Clin Endocrinol Metab; 1997 Jan; 82(1):265-74. PubMed ID: 8989272
[TBL] [Abstract][Full Text] [Related]
32. Alendronate release from calcium phosphate cement for bone regeneration in osteoporotic conditions.
van Houdt CIA; Gabbai-Armelin PR; Lopez-Perez PM; Ulrich DJO; Jansen JA; Renno ACM; van den Beucken JJJP
Sci Rep; 2018 Oct; 8(1):15398. PubMed ID: 30337567
[TBL] [Abstract][Full Text] [Related]
33. Alendronate influences bending force of femoral diaphysis after orchidectomy in rats.
Huuskonen J; Arnala I; Olkkonen H; Alhava E
Ann Chir Gynaecol; 2001; 90(2):109-14. PubMed ID: 11459259
[TBL] [Abstract][Full Text] [Related]
34. Novel combinatorial transdermal drug delivery of alendronate with risedronate for the treatment of osteoporosis.
Kong F; Jia B; Cui P; Wang D
Acta Biochim Pol; 2019 Dec; 66(4):463-467. PubMed ID: 31846272
[TBL] [Abstract][Full Text] [Related]
35. Hyaluronic acid-containing ethosomes as a potential carrier for transdermal drug delivery.
Xie J; Ji Y; Xue W; Ma D; Hu Y
Colloids Surf B Biointerfaces; 2018 Dec; 172():323-329. PubMed ID: 30176512
[TBL] [Abstract][Full Text] [Related]
36. Liquid crystalline pharmacogel based enhanced transdermal delivery of propranolol hydrochloride.
Namdeo A; Jain N
J Control Release; 2002 Aug; 82(2-3):223-36. PubMed ID: 12175739
[TBL] [Abstract][Full Text] [Related]
37. Hyaluronate - parathyroid hormone peptide conjugate for transdermal treatment of osteoporosis.
Cho M; Han S; Kim H; Kim KS; Hahn SK
J Biomater Sci Polym Ed; 2018; 29(7-9):793-804. PubMed ID: 29115187
[TBL] [Abstract][Full Text] [Related]
38. Microstructure and properties of alendronate-loaded calcium phosphate cement.
Shen Z; Yu T; Ye J
Mater Sci Eng C Mater Biol Appl; 2014 Sep; 42():303-11. PubMed ID: 25063123
[TBL] [Abstract][Full Text] [Related]
39. Design, formulation and optimization of valsartan transdermal gel containing iso-eucalyptol as novel permeation enhancer: preclinical assessment of pharmacokinetics in Wistar albino rats.
Ahad A; Aqil M; Kohli K; Sultana Y; Mujeeb M
Expert Opin Drug Deliv; 2014 Aug; 11(8):1149-62. PubMed ID: 24830648
[TBL] [Abstract][Full Text] [Related]
40. Calcium phosphate nanoparticles functionalized with alendronate-conjugated polyethylene glycol (PEG) for the treatment of bone metastasis.
Chu W; Huang Y; Yang C; Liao Y; Zhang X; Yan M; Cui S; Zhao C
Int J Pharm; 2017 Jan; 516(1-2):352-363. PubMed ID: 27887884
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
